NovaPulse
Treatment for Peripheral Artery Disease
StartupNovaPulse is a Or Yehuda-based startup in the Health Tech & Life Sciences sector, established in 2022. Treatment for Peripheral Artery Disease. NovaPulse was founded by Shaul Ozeri. The company has 1-10 employees. Core technologies: Materials & Substances, Implants.
The company follows a B2C/B2B business model. Product stage: Clinical Trial.
- StageSeed
- ProductClinical Trial
- ModelB2C, B2B
- Employees1-10
- HQOr Yehuda
- Last RoundUndisclosed
Shaul Ozeri
2 articles covered by sources including www.medxelerator.com,
www.sponser.co.il.
What does NovaPulse do?
NovaPulse is a bioconvergence company specializing in the multibillion-dollar peripheral artery disease market. The company is focused on helping the millions of claudication patients who suffer from pain and have trouble walking because of insufficient blood supply to their legs. NovaPulse is the brainchild of the MEDX Xelerator incubator.
Who founded NovaPulse?
NovaPulse was founded in 2022 by Shaul Ozeri.
What sector is NovaPulse in?
NovaPulse operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is NovaPulse located?
NovaPulse is based in Ariel Sharon Blvd 8, Or Yehuda, Israel.